Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Rajeshwari S. Punekar, Kathleen M. Fox, Carly J. Paoli, Akshara Richhariya, Mark J. Cziraky, Shravanthi R. Gandra & Peter P. Toth. (2017) Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study. Current Medical Research and Opinion 33:5, pages 869-876.
Read now
Read now
Furio Colivicchi, Catarina Sternhufvud & Sanjay K Gandhi. (2015) Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials. ClinicoEconomics and Outcomes Research 7, pages 555-565.
Read now
Read now
Elizabeth Marrett, Changgeng Zhao, Ning Jackie Zhang, Qiaoyi Zhang, Dena R Ramey, Joanne E Tomassini, Andrew M Tershakovec & David R Neff. (2014) Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US. Vascular Health and Risk Management 10, pages 237-246.
Read now
Read now
JoAnne M Foody, Peter P Toth, Andrew M Tershakovec, Thomas Musliner, Joanne E Tomassini, Robert S Lowe, David R Neff & Harry R Davis. (2014) Efficacy and safety of ezetimibe plus atorvastatin therapy. Clinical Lipidology 9:4, pages 441-470.
Read now
Read now
JoAnne M Foody, Peter P Toth, Joanne E Tomassini, Shiva Sajjan, Dena R Ramey, David Neff, Andrew M Tershakovec, Henry Hu & Kaan Tunceli. (2013) Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. Vascular Health and Risk Management 9, pages 719-727.
Read now
Read now
C. Montouchet, L. Ruff & S. Balu. (2013) Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective. Journal of Medical Economics 16:7, pages 907-916.
Read now
Read now
Andrew van Herick, C Andy Schuetz, Peter Alperin, Michael F Bullano, Sanjeev Balu & Sanjay Gandhi. (2012) The impact of initial statin treatment decisions on cardiovascular outcomes in clinical care settings: estimates using the Archimedes Model. ClinicoEconomics and Outcomes Research 4, pages 337-347.
Read now
Read now
C. Andy Schuetz, Andrew van Herick, Peter Alperin, Barbara Peskin, Judith Hsia & Sanjay Gandhi. (2012) Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model. Journal of Medical Economics 15:6, pages 1118-1129.
Read now
Read now
Articles from other publishers (6)
James P. Burke, Ross J. SimpsonJr.Jr., Carly J. Paoli, Jeffrey T. McPheeters & Shravanthi R. Gandra. (2016) Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy. Journal of Clinical Lipidology 10:6, pages 1470-1480.e3.
Crossref
Crossref
F. M. de Vries, J. Voorham, E. Hak & P. Denig. (2016) Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive study. International Journal of Clinical Practice 70:6, pages 482-492.
Crossref
Crossref
Michel Krempf, Ross J Simpson, Dena Rosen Ramey, Philippe Brudi, Hilde Giezek, Joanne E Tomassini, Raymond Lee & Michel Farnier. (2015) Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey. Lipids in Health and Disease 14:1.
Crossref
Crossref
Baishali M. Ambegaonkar, Diane Tipping, Adam B. Polis, Joanne E. Tomassini & Andrew M. Tershakovec. (2014) Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis. Atherosclerosis 237:2, pages 829-837.
Crossref
Crossref
Peter P. Toth, JoAnne M. Foody, Joanne E. Tomassini, Shiva G. Sajjan, Dena R. Ramey, David R. Neff, Andrew M. Tershakovec, X. Henry Hu & Kaan Tunceli. (2014) Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. Journal of Clinical Lipidology 8:1, pages 107-116.
Crossref
Crossref
Ross J. SimpsonJr.Jr., Kaan Tunceli, Dena R. Ramey, David R. Neff, David M. Kern, Hui-Min Hsieh, Debra A. Wertz, Judith J. Stephenson, Elizabeth Marrett, Joanne E. Tomassini & Terry A. Jacobson. (2013) Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting. Journal of Clinical Lipidology 7:5, pages 399-407.
Crossref
Crossref